Riverbrae - Snookered, page-15

A deal with Ellume has been done. In answer to your question, no, they aren't responsible for supplying and manufacturing the whole test insert/cartridge unless something has changed from the original ann back in Oct '16:

"Anteo Diagnostics Limited (ASX: ADO) is pleased to announce that it has entered a long term supply arrangement with Ellume Pty Ltd. based in Brisbane, Australia. (This = a deal)

Established in 2010, Ellume has developed a pioneering quantum dot detection system combining nano-technology and unique opto-electronics resulting in a next generation immunoassay platform. Ellume has used this technology to create products distinguished by their technical performance, simplicity of design, ease of use, rapid time to result and connectivity.

Anteo worked with Ellume in the early stages of quantum dot enablement to deliver a customised formulation of Anteo’s unique metal-ion based nanometre-thin chemistry.

Anteo COO Ms Tamara Mills said, “We are pleased to see that Anteo’s technology has delivered a strong technical proposition and commercial solution for Ellume. We believe Anteo’s platform technology is well placed to enable the next wave of breakthrough PoC technologies, particularly as the limitations of the traditional biomolecule coupling methods struggle to meet the demands associated with nano-technology.”

Ellume Managing Director, Dr Sean Parsons, said, “Anteo technology forms an important layer in our proprietary quantum-dot based technology and we are pleased to have entered into this long-term agreement.”

The undisclosed commercial arrangement (a deal, but not sure if it's a good one or not) shall see Ellume utilise Anteo’s proprietary technology across its suite of pipeline products. The first to be launched influenza product will be released to the professional market in 2017. Other pipeline products include Respiratory Syncytial Virus, Group A Streptococcus and Chlamydia."


All IMHO, FWIW, DYOR, TJAB, blah blah blah....